Pharmacokinetics and bioavailability of pentoxifylline in healthy volunteers-a comparative study of three oral formulations

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 43, Issue 2, 1997, Pages 193-196

  Pokrajac, Milena ^a   Miljković, Branislava ^a   Simić, Dragan ^b   Brzaković, Branka ^a   Galetin, Aleksandra ^a  

^a Faculty of Pharmacy   (Serbia)

^b Clin Ctr Dr Dragisa Misovic ^*  (Serbia)

Author keywords

Comparative bioavailability; Pentoxifylline; Pharmacokinetics

Indexed keywords

PENTOXIFYLLINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG FORMULATION; FILM COATING; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0031398728     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(96)00015-X     Document Type: Article

References (10)

1. B. Beermann, R. Ings, J. Mansby, J. Chamberlain, A. McDonald, Kinetics of intravenous and oral pentoxifylline in healthy subjects, Clin. Pharmacol. Ther. 37 (1985) 25-28.
2. 14 C - pentoxifylline in healthy volunteers, Arzneim.-Forsch. Drug Res. 39 (1989) 512-517.
3. I. Raz, J. Ben-David, Z. Hussein, E. Samara, Comparative pharmacokinetic analysis of novel sustained-release dosage forms of pentoxifylline in healthy subjects, Int. J. Clin. Pharmacol. Ther. Toxicol. 26 (1988) 206-208.
4. A. Garnier-Moiroux, J.-M. Poirier, G. Cheymol, P. Jaillon, High-performance liquid chromatographic determination of pentoxifylline and its hydroxy metabolite in human plasma, J. Chromatogr.-Biomed. Appl. 416 (1987) 183-188.
5. A.C. Cartwright, U. Gundert-Remy, G. Raus, I. McGilveray, T. Salmonson, S. Walters, International harmonization and consensus DIA meeting on bioavailability and bioequivalence testing requirements and standards, Drug Inf. J. 25 (1991) 471-482.
6. V.W. Steinijans, H.-U. Schulz, Bioequivalence assessment: methods and applications, Int. J. Clin. Pharmacol. Ther. Toxicol. 30 (1) (1992) 1-63.
7. V.P. Shah, K.K. Midha, D. Shrikant, et al., Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Int. J. Pharm. 82 (1992) 1-7.
8. W.J. Westlake, Use of confidence intervals in analysis of comparative bioavailability trials, J. Pharm. Sci. 61 (1972) 1340-1342.
9. H. Fluehler, A.P. Grieve, D. Mandallaz, J. Mau, H.A. Moser, Bayesian approach to bioequivalence assessment: an example, J. Pharm. Sci. 72 (1983) 1178-1181.
10. I. Meineke, A simple basic program for the calculation of nonparametric confidence intervals in bioequivalence testing, Comput. Methods Program. Biomed. 24 (1987) 65-71.